Moses Lake Pharmacy Recalls Sterile Ethyl Alcohol Syringes Due to Sterility Concerns
JD & SN Inc., dba Moses Lake Professional Pharmacy, is recalling 30 mL syringes of 100% sterile ethyl alcohol for injection due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a lack of assurance of sterility in an injectable product, which poses a significant risk of serious health consequences.
Plain-English summary
JD & SN Inc., dba Moses Lake Professional Pharmacy, is recalling 30 mL syringes of 100% sterile ethyl alcohol for injection. The product is a prescription-only injectable solution with a code of t05192015@11.
The recall was initiated because of a lack of assurance of sterility. The source text indicates that all sterile human compounded drugs within their expiry date are affected by this issue.
Consumers who have this product should contact their healthcare provider or the recalling firm for further instructions. The recall is classified as FDA Class II.
The recalled product
- Product
- ETHYL ALCOHOL (STERILE FOR INJECTION) 100%, Injectable Solution, 200 PROOF, 30 mL syringe, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA 98837, (509)764-2314
- Category
- Drug — Injectable Solution
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- t05192015@11
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 101 recalled by JD & SN Inc., dba Moses Lake Professional Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 101 products in this recall →Related recalls
Same manufacturer · JD & SN Inc., dba Moses Lake Professional Pharmacy
See all →- SevereFDA Recalls Estradiol Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Sodium Tetradecyl Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Six Trimix Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereMoses Lake Pharmacy Recalls Compounded Chorionic Gonadotropin Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Compounded Progesterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04
Same hazard · sterility
See all →- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
Similar recalls
- HighInjectable Ethyl Alcohol 95% Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2023-02-01
- SevereDowning Labs Recalls DMAE Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereWells Pharmacy Recalls Mitomycin Solution Injectable Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereEdge Pharma Recalls Methotrexate Syringes Due to Sterility Testing Concerns
FDA (Drugs) · 2021-01-20
- SevereMoxifloxacin Ophthalmic Injection Syringes Recalled for Sterility Risk
FDA (Drugs) · 2022-02-02
- SevereAssurance Infusion Recalls Morphine Syringes Due to Sterility Concerns
FDA (Drugs) · 2020-01-22